Recruiting NA INTERVENTIONAL 2-arm
NCT06313450
De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Interventions
conventional radiotherapy de-escalated radiotherapy
Updated 3 times since 2024 Last updated: Mar 15, 2024 Started: Mar 4, 2024 Primary completion: Feb 1, 2026 Completion: Feb 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on IMMUNOTHERAPY and Nasopharyngeal Carcinoma, this trial is actively recruiting participants. The trial is conducted by Sun Yat-sen University and has accumulated 3 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Sun Yat-sen University
Data source: Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .